Genetic testing company Fulgent Genetics announced the launch of Picture Genetics, a new line of at-home genetic testing targeting consumers. Picture Genetics will offer three separate consumer-initiated screening tests, which will enable individuals to access Fulgent’s advanced genetic testing and analytics capabilities from the ease and comfort of home...

Mayo Clinic and Google said they will jointly develop artificial intelligence (AI)-based diagnostics and carry out medical research using Google Cloud to store and secure the data, through a 10-year strategic partnership whose value was not disclosed. The partners said their collaboration is intended to advance healthcare by applying computing...

Scientists at Cold Spring Harbor Laboratory (CSHL) say they have found a way to tackle the problem of drug resistance and stop the growth of pancreatic ductal adenocarcinoma (PDA) tumors in mice. Their findings (“Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer”) are published...

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark (since acquired by Agilent Technologies) received authorization to market HercepTest. The immunohistochemistry (IHC) assay was designed to detect human epidermal growth factor receptor 2 (HER2)...

Myriad Genetics said today it will assess the clinical utility of its Prolaris test in men diagnosed with prostate cancer, through a collaboration with the Leeds Centre for Personalised Medicine and Health (LCPMH) whose value was not disclosed. Myriad and LCPMH plan to partner on a study designed to evaluate the...

LunaPBC, the public-benefit corporation which oversees the LunaDNA community-owned genomic and health data platform, said today that members will now be able to access their electronic health records (EHRs) in the platform via Medfusion’s Patient Data application program interfaces (APIs), through a collaboration whose value was not disclosed. The integration,...

Genomic Diagnostics company Veracyte says new data demonstrates the clinical and analytical validity of its Afirma Xpression Atlas (XA) genomic test, which was developed to help guide surgery and treatment decisions for patients with likely or confirmed thyroid cancer. This data is reported online in the journal Frontiers in Endocrinology. Veracyte develops...

Diagnosing head and neck cancers is challenging. It is particularly difficult to distinguish pulmonary metastases of head and neck squamous cell carcinoma (HNSC) from primary lung squamous cell carcinomas (LUSCs). However, differentiating these from each another can have important clinical implications. Now, a team of researchers has developed a machine learning...

The CRISPR-Chip garnered much attention earlier this year when the novel graphene-based biosensor CRISPR-Cas technology was introduced in a Nature Biomedical Engineering publication in March. This week, the two companies that have been straddling the technology that is able to detect a specific genetic mutation from a sample without the...

More than 67 actionable clinical discoveries were made through deep longitudinal genomic analysis by a group led by Michael Snyder, MD, chair of the genetics department at Stanford University. The Stanford group’s pioneering precision health study is published in the May issue of Nature Medicine. To carry out the study,...